BioSurgery Market By Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Mesh, Soft Tissue Attachments, Stapler, and Bone Graft Substitutes), By Application (Orthopedic, Gynecology, Cardiovascular, and Reconstructive), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI421520 | Publish Date: April 2024 | No. of Pages: 180

Global BioSurgery Market Overview

Biosurgery has opened a new paradigm in surgical care regenerative healing, and tissue and wound management. The different products beneath biosurgery have produced great interest between the patient and surgeons and are anticipated to get traction in many medical specialties involved gynecology, orthopedic, cardiovascular, spine- related treatment, and neurosurgery. Biosurgery has created novel potential in regenerative soothing with the correct mix of synthetics and biologics. Healthcare sector players are gradually focused on boosting new outlook of the market by developing new biomaterials.

Global BioSurgery Market Drivers & Restraints

Rising in numbers of surgeries

Changing eating habits and lifestyles have shown a significant rise in the occurrence of obesity and various lifestyle disorders. As the number of surgery performed increased all over the globe every year is the major propelling factor for the growth of the target market. Biosurgery products play a critical role in healing wounds, controlling blood loss, and in bolting the surgical sites while various types of surgeries. As per the (NCBI) National Center for Biotechnology Information (US), there has been a major rise in the number of surgical procedures in the US from last few years, and the trend of increasing surgical procedure is anticipated to continuous growth in the coming years.

High price of biosurgery products

Now-a-days, the competition for the biosurgery products market is extremely competitive in terms of pricing due to the more competitive intensity between the existing key players. Many of the biosurgery products are the high priced products. This high price of surgical procedure is not affordable for the vast section of the target patient population. As the increasing in the price of bio surgical product gives rise to hike to the surgical procedure is the major restraining factor for the growth of the target market.

Global BioSurgery Market Segmentations & Regional Insights

The biosurgery market is segmented based on product, application, and region.

On the basis of product, the biosurgery market is segmented into fibrin & collagen sealant, hemostats, adhesion barriers, biological mesh, soft tissue attachments, stapler, and bone graft substitutes. Based on application, the target market is segmented into orthopedic, gynecology, cardiovascular, and reconstructive.

Regional Insights:

On region the biosurgery market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to have the largest market size in the biosurgery market over the forecast period. North America is expected to dominate because of the presence of increasing volume of surgical procedures performed, large number of hospitals, well-developed healthcare system and presence of ruling market players in the region. Additionally, The Asia Pacific market is anticipated to observer the largest growth rate over the forecast period due to the increasing prevalence of chronic diseases in the region.

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Million & CAGR from 2024 to 2034

Market Segmentation

By Product- Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Mesh, Soft Tissue Attachments, Stapler, and Bone Graft Substitutes

By Application- Orthopedic, Gynecology, Cardiovascular, and Reconstructive

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global biosurgery market report based on product, application, and region:

Biosurgery Market, By Product:

  • Fibrin & Collagen Sealant
  • Hemostats
  • Adhesion Barriers
  • Biological Mesh
  • Soft Tissue Attachments
  • Stapler
  • Bone Graft Substitutes

Biosurgery Market, By Application:

  • Orthopedic
  • Gynecology
  • Cardiovascular
  • Reconstructive

Biosurgery Market, By Region:

  • North America
    • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • U.S.
      • Canada

Global BioSurgery Market Competitive Landscape & Key Players

The key players operating the biosurgery market includes Baxter International Inc., C.R. Bard, Johnson & Johnson, Medtronic plc., Sanofi Group, B. Braun Melsungen AG, MAQUET Holding B.V. & Co. KG., Cryolife, Inc., Stryker Corporation, and Hemostasis, LLC. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, on 20 February 2020, Baxter's latest acquisition to fuels advanced surgery arm.

Global BioSurgery Market Company Profile

  • Baxter International Inc.
  • C.R. Bard
  • Johnson & Johnson
  • Medtronic plc.
  • Sanofi Group
  • B. Braun Melsungen AG
  • MAQUET Holding B.V. & Co. KG.
  • Cryolife, Inc.
  • Stryker Corporation
  • Hemostasis, LLC

FAQs

The Global BioSurgery Market is valued at US$12.0 billion in 2020

The Global BioSurgery Market is projected to increase at a CAGR of 7.8% during the forecast period.

The global biosurgery market is segmented based on product, application, and region.

Rising in numbers of surgeries and high price of biosurgery products

North America is expected to dominate because of the presence of increasing volume of surgical procedures performed, large number of hospitals, well-developed healthcare system and presence of ruling market players in the region.

Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.